Hospital resources for urokinase/recombinant tissue-type plasminogen activator therapy for acute stroke in Beijing

Surg Neurol. 2009 Aug:72 Suppl 1:S2-7. doi: 10.1016/j.surneu.2007.12.028. Epub 2008 Apr 18.

Abstract

Background: We focus on the current resource level for UK/rt-PA therapy in hospitals in Beijing to design strategies for improving treatment for stroke patients.

Methods: The data were collected through surveys of 124 grade II or higher hospitals in Bejing, which provide stroke treatment, from July to September 2006.

Results: Of the surveyed hospitals, 50% and 92.6% were capable in providing intravenous UK/rt-PA treatment and head CT service, respectively. Eight (7.4%) hospitals have specialized stroke units and 106 (98.1%) hospitals have EDs. We found significant differences between hospitals that can provide UK/rt-PA therapy and the hospitals that cannot in the levels of specialists and clinical care capacity as follows: CT (100% vs 85.2%; P = 0.01), CTA (46.3% vs 22.2%; P = .014), MRI (66.7% vs 22.2%; P = .000), MRA (57.4% vs 20.4%; P = .000), DWI (48.1% vs 9.3%; P = .000), PWI (31.5% vs 5.6%; P = .001), DSA (63.0% vs 25.9%; P = .000), neurologists (100% vs 79.6%; P = .001), neurosurgeons (75.9% vs 44.4%; P = .002), carotid stenting (33.3% vs 5.6%; P = .000), stroke unit (14.8% vs 0%; P = .01), and acute stroke care system (31.5% vs 0%; P = .000).

Conclusion: The thrombolysis treatment facilities in Beijing are not sufficient. Hospitals in Beijing should organize stroke-related medical sources.

Publication types

  • Comparative Study
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adult
  • Aged
  • China
  • Emergency Service, Hospital / statistics & numerical data*
  • Emergency Treatment
  • Female
  • Fibrinolytic Agents / therapeutic use*
  • Health Care Rationing / statistics & numerical data
  • Health Care Surveys
  • Health Resources / supply & distribution*
  • Hospital Units / statistics & numerical data
  • Humans
  • Male
  • Middle Aged
  • Resource Allocation / statistics & numerical data*
  • Retrospective Studies
  • Stroke / diagnosis
  • Stroke / drug therapy*
  • Stroke / prevention & control
  • Thrombolytic Therapy / methods*
  • Tissue Plasminogen Activator / therapeutic use*
  • Urokinase-Type Plasminogen Activator / therapeutic use*
  • Workforce

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator
  • Urokinase-Type Plasminogen Activator